|
Forecast Period
|
2026-2030
|
|
Market Size (2024)
|
USD
58.45 Billion
|
|
CAGR (2025-2030)
|
5.39%
|
|
Fastest Growing Segment
|
Cardiovascular Catheter
|
|
Largest Market
|
North
America
|
|
Market Size (2030)
|
USD 80.27 Billion
|
Market Overview
Global Catheter Market was valued at USD 58.45 Billion
in 2024 and is expected to reach USD 80.27 Billion by 2030 with a CAGR of 5.39%
during the forecast period. The global catheter market has witnessed substantial growth in recent
years, driven by an increasing prevalence of chronic diseases, a growing aging
population, and advancements in medical technology. Catheters are essential
medical devices used in various applications, including cardiovascular,
urinary, neurovascular, and intravenous procedures. Their widespread use in
hospitals, ambulatory surgical centers, and home healthcare settings has
contributed to the market’s expansion. Additionally, rising awareness about
minimally invasive procedures has further accelerated demand for innovative
catheter technologies. One of the key factors fueling the growth of the global
catheter market is the rising incidence of cardiovascular diseases (CVDs) and
urinary disorders. Cardiovascular catheters, such as angiography catheters and
electrophysiology catheters, are extensively used in the diagnosis and
treatment of heart-related conditions. Similarly, urinary catheters are crucial
for patients suffering from urinary incontinence and other bladder-related
disorders, particularly among the elderly population. The growing burden of
chronic diseases, coupled with an increasing number of surgical procedures, is
expected to drive continued demand for catheters.
Technological advancements
in catheter design and materials have played a pivotal role in market
expansion. The development of antimicrobial-coated and drug-eluting catheters
has significantly reduced the risk of infections, a major concern associated with
catheterization. Additionally, the advent of smart catheters equipped with
sensors for real-time monitoring has enhanced patient safety and treatment
outcomes. Companies are also focusing on the use of biocompatible materials to
improve the durability and efficiency of catheters, making them more
patient-friendly.
Key Market Drivers
Rising Prevalence of
Chronic Diseases
The global catheter market is experiencing
substantial growth, primarily driven by the increasing prevalence of chronic
diseases such as cardiovascular disorders, diabetes, urinary incontinence, and
neurological conditions. These medical conditions often require continuous
treatment, surgical interventions, and hospital care, where catheters play a
critical role in patient management. Additionally, the growing geriatric
population, advancements in catheter technology, and the expansion of
healthcare facilities worldwide have further accelerated the demand for
catheters.
Cardiovascular diseases (CVDs) are among the
leading causes of death worldwide, with conditions such as coronary artery
disease, heart failure, and arrhythmias necessitating catheter-based
procedures. According to the World Health Organization (WHO), CVDs account
for approximately 17.9 million deaths annually, highlighting the need for
advanced cardiac interventions. Catheters are extensively used in
procedures like angioplasty, electrophysiology studies, and cardiac
catheterization to diagnose and treat various heart conditions. With the rising
adoption of minimally invasive techniques, demand for advanced cardiovascular
catheters, including balloon catheters, electrophysiology catheters, and
guiding catheters, has surged. Additionally, the increasing number of
catheter-based cardiac ablation procedures to treat atrial fibrillation is
further driving the market. Technological innovations, such as steerable
catheters and bioresorbable stents, are also enhancing the effectiveness of
catheter-based cardiac interventions.
Diabetes is another major contributor to the rising
demand for catheters, as it is associated with multiple complications that
often require catheter-based interventions. Diabetic patients are at a higher
risk of developing kidney disease, neuropathy, and urinary retention, leading
to increased use of dialysis catheters, insulin infusion catheters, and urinary
catheters. The International Diabetes Federation (IDF) estimates that over
537 million adults were living with diabetes in 2021, with the number expected
to reach 783 million by 2045. For diabetic patients with end-stage renal
disease (ESRD), hemodialysis becomes a critical treatment, necessitating the
use of tunneled and non-tunneled dialysis catheters. Furthermore, insulin pump
therapy, which uses catheter-based infusion sets, has gained popularity for
better glycemic control, further boosting market growth.
Urinary incontinence and other bladder-related
disorders are becoming increasingly prevalent, particularly among the aging
population. Conditions such as benign prostatic hyperplasia (BPH), neurogenic
bladder, and spinal cord injuries necessitate catheterization for urine
drainage. Foley catheters, intermittent catheters, and external catheters are
widely used for managing urinary retention and incontinence. The aging global
population is a key factor contributing to the rising demand for urinary
catheters. According to the United Nations, the number of people aged 65 and
older is expected to double by 2050, reaching 1.5 billion. As age-related
urological disorders become more common, the need for long-term catheter use in
home healthcare settings is increasing. Additionally, the growing acceptance of
self-catheterization for greater patient independence is boosting market expansion.
Increasing Hospitalization and Surgical Procedures
The global catheter market is experiencing
substantial growth, primarily driven by the increasing number of
hospitalizations and surgical procedures worldwide. Catheters are essential
medical devices used in a wide range of diagnostic and therapeutic applications,
making them indispensable in modern healthcare systems. The rising prevalence
of chronic diseases, coupled with advancements in medical technology, has
significantly boosted the demand for catheters. As healthcare providers seek to
enhance patient outcomes and reduce complications, the catheter market is
poised for continuous expansion. According to the World Health Organization (WHO), millions of
individuals undergo surgical procedures annually, with surgical interventions
contributing to approximately 13% of the global disability-adjusted life years
(DALYs).
A significant driver of the global catheter market
is the increasing number of surgical interventions across various medical
specialties. Cardiovascular diseases (CVDs), which are among the leading causes
of mortality worldwide, require frequent medical interventions that rely on
catheterization. Procedures such as angioplasty, stent placement, and
electrophysiology studies extensively use cardiovascular catheters. The rising
incidence of heart diseases, driven by factors such as aging populations, sedentary
lifestyles, and unhealthy diets, has led to an increasing number of cardiac
surgeries and catheter-based treatments.
Similarly, the urology sector has witnessed a surge
in demand for urinary catheters due to the growing prevalence of urinary
incontinence, kidney disorders, and prostate conditions. Urinary catheters are
widely used in post-surgical care, long-term care settings, and home healthcare
for patients with mobility limitations. The increasing geriatric population,
which is more susceptible to urological disorders, is further propelling market
growth. Additionally, advancements in catheter technology, such as antimicrobial
and hydrophilic-coated urinary catheters, have enhanced patient safety by
reducing the risk of infections.
The rising prevalence of chronic diseases such as
diabetes, cancer, kidney diseases, and neurological disorders has led to a
significant increase in hospital admissions. Many patients requiring long-term
hospitalization depend on catheters for various medical procedures, including
intravenous drug administration, dialysis, and fluid drainage. The growing
burden of chronic kidney disease (CKD), particularly among aging populations,
has resulted in an increased demand for dialysis catheters. With millions of people
worldwide requiring dialysis treatments, the market for hemodialysis and
peritoneal dialysis catheters has expanded considerably.
In oncology, catheters play a vital role in
chemotherapy drug administration and palliative care. Patients undergoing
chemotherapy often require long-term vascular access, which has led to an
increasing demand for peripherally inserted central catheters (PICCs) and
implantable ports. The rising incidence of cancer, along with the expansion of
cancer treatment centers, is further fueling the need for these devices. According to the National
Cancer Institute, in 2024, approximately 2,001,140 new cancer cases were
diagnosed in the United States, and 611,720 individuals succumbed to the
disease.
Innovations in catheter technology have
significantly improved patient safety, comfort, and procedural efficiency. The
development of antimicrobial-coated catheters has helped reduce the risk of
catheter-associated infections (CAIs), a major concern in healthcare settings.
Similarly, hydrophilic-coated catheters, which reduce friction during insertion
and removal, have enhanced patient comfort and minimized trauma to the urethra
or blood vessels. Another notable advancement is the integration of catheter-based
drug delivery systems, which allow for targeted and controlled medication
release. These systems are widely used in the treatment of cardiovascular
diseases and cancer, where precision is critical for effective therapy. The
growing adoption of catheter-based interventions, particularly in minimally
invasive surgeries (MIS), has further expanded market opportunities. Minimally
invasive procedures have gained popularity due to their benefits, including
shorter hospital stays, reduced post-operative pain, and faster recovery times.
Catheters play a crucial role in these procedures, such as robotic-assisted
surgeries, laparoscopic interventions, and endovascular therapies. The
increasing acceptance of minimally invasive techniques across healthcare
facilities is expected to drive further demand for catheters.
Download Free Sample Report
Key Market Challenges
Pricing Pressure and Reimbursement Issues
The catheter market is highly competitive, leading
to intense pricing pressures among manufacturers. Healthcare providers and
governments, particularly in cost-sensitive regions, demand lower prices for
medical devices, reducing profit margins for companies. Reimbursement policies
also vary across countries, affecting the affordability of catheters for
patients. In some regions, limited insurance coverage or restrictive
reimbursement policies make advanced catheter technologies less accessible,
hindering market growth.
Supply Chain Disruptions and Material Shortages
The global supply chain for medical devices,
including catheters, has faced significant disruptions due to geopolitical
tensions, trade restrictions, and logistical bottlenecks. The COVID-19 pandemic
further exposed vulnerabilities in supply chains, leading to shortages of raw
materials such as silicone, latex, and polyurethane—key components in catheter
manufacturing. These disruptions increase production costs and lead to delays
in product availability, affecting both manufacturers and healthcare providers.
Key Market Trends
Technological Advancements
The global catheter market is experiencing
significant growth, driven primarily by rapid technological advancements.
Catheters, which are essential medical devices used for drainage,
administration of fluids, or access to various parts of the body, have seen
notable improvements in material composition, design, and functionality.
Innovations in catheter technology are enhancing patient comfort, reducing the
risk of infections, and improving overall procedural efficiency, making them
indispensable in modern healthcare.
One of the most significant technological
advancements in the catheter market is the development of biocompatible
materials and coatings. Traditional catheters were often associated with
complications such as infections, thrombosis, and tissue irritation. However,
the introduction of antimicrobial coatings and hydrophilic surface
modifications has significantly reduced these risks. These coatings not only
prevent bacterial colonization but also minimize friction, ensuring smoother
insertion and reduced patient discomfort. Additionally, the use of silicone and
polyurethane in catheter manufacturing has improved flexibility, durability,
and compatibility with the human body.
The integration of smart technology into catheters
is another transformative trend. Sensor-enabled catheters are being developed
to provide real-time monitoring of physiological parameters, such as pressure,
temperature, and flow rates. These advancements are particularly beneficial in
critical care and chronic disease management, where continuous monitoring is
essential. For example, in urinary catheters, embedded sensors can detect
infections early, alerting healthcare providers before complications arise.
Similarly, cardiovascular catheters equipped with pressure sensors help in
assessing hemodynamic parameters, enhancing precision in diagnostic and
interventional procedures. The demand for minimally invasive procedures has led
to the development of catheters with improved steerability and navigation
capabilities. Innovations such as robotic-assisted catheter systems and
microcatheters are making complex procedures more precise and safer. Steerable
catheters allow for enhanced maneuverability within the body, reducing trauma
to surrounding tissues and improving procedural success rates. These
advancements are particularly crucial in neurovascular and cardiovascular
interventions, where precise navigation through intricate anatomical structures
is required.
3D printing technology is revolutionizing the
catheter market by enabling the production of patient-specific designs. This
advancement is particularly beneficial in pediatric and complex cases where
standard catheter sizes may not be suitable. Customized catheters improve
patient outcomes by ensuring a better fit, reducing complications, and
enhancing overall procedural efficiency. Moreover, 3D printing allows for rapid
prototyping and iterative improvements in catheter design, accelerating the
pace of innovation in the industry.
Drug-eluting catheters, which release therapeutic
agents directly into the bloodstream or targeted areas, are another
breakthrough in catheter technology. These catheters are particularly useful in
treating conditions such as cardiovascular diseases and infections. For
instance, drug-coated balloon catheters used in angioplasty procedures help
prevent restenosis by delivering anti-proliferative drugs to the affected
arteries. This innovation has significantly improved long-term outcomes for
patients undergoing catheter-based interventions. As technological advancements
continue to shape the catheter market, the future looks promising with the
introduction of more intelligent, biocompatible, and minimally invasive
solutions. The convergence of robotics, artificial intelligence, and nanotechnology
in catheter development is expected to drive further innovation. With an
increasing focus on patient safety, infection control, and procedural
efficiency, the catheter industry is set to witness sustained growth, making it
a critical component of modern medical care.
Segmental Insights
Product Type Insights
Based on Product Type, the Cardiovascular Catheter segment
has emerged as the fastest-growing segment in the Global Catheter Market in 2024,
driven by increasing demand for minimally
invasive procedures and the rising prevalence of cardiovascular diseases
(CVDs). Among the various product types, the cardiovascular catheter segment
has emerged as the fastest-growing segment, fueled by advancements in
catheterization techniques, growing awareness about early diagnosis and
treatment of heart conditions, and the increasing adoption of catheter-based
interventions. One of the primary drivers of this rapid growth is the rising
global burden of cardiovascular diseases. According to the World Health
Organization (WHO), CVDs remain the leading cause of mortality worldwide,
accounting for nearly 18 million deaths annually. This growing prevalence has
spurred demand for effective diagnostic and interventional procedures, with
cardiovascular catheters playing a crucial role in procedures such as
angiography, angioplasty, and electrophysiology studies. The shift toward less
invasive treatment options has further strengthened the market, as
catheter-based procedures offer reduced recovery times and lower risks compared
to traditional open-heart surgeries.
Technological advancements
in catheter designs have also played a significant role in the segment’s
growth. Innovations such as drug-coated balloon catheters, bioresorbable
scaffolds, and advanced electrophysiology catheters have improved procedural
outcomes, making cardiovascular catheterization more effective and accessible.
Additionally, the integration of robotics and artificial intelligence (AI) in
catheterization procedures has enhanced precision and efficiency, further
driving adoption among healthcare providers.
Download Free Sample Report
Regional Insights
Based on Region, North America emerged as the
dominating region in the Global Catheter Market in 2024, Factors such as an
increasing prevalence of chronic diseases, technological advancements, a
well-established healthcare infrastructure, and a rising aging population have
significantly contributed to the region’s leading position. The demand for
catheters in North America continues to surge, particularly due to the rising
incidence of cardiovascular diseases, urinary disorders, and the growing
adoption of minimally invasive procedures.
One of the primary reasons
for North America's dominance in the Global Catheter Market is the high
prevalence of chronic diseases such as cardiovascular disorders, diabetes, and
kidney-related ailments. According to the Centers for Disease Control and Prevention
(CDC), heart disease remains a leading cause of death in the United States,
driving demand for cardiovascular catheters. Similarly, the increasing
number of patients suffering from urinary incontinence and bladder dysfunctions
has led to a surge in demand for urinary catheters. Moreover, technological
advancements have played a crucial role in the expansion of the North American
catheter market. Innovations in catheter materials, drug-coated catheters, and
smart catheters with sensors have enhanced patient safety and procedural
efficiency. The adoption of robot-assisted catheter-based interventions has
further bolstered the region’s dominance, as healthcare providers continue to
embrace minimally invasive surgical techniques. The well-established healthcare
infrastructure in North America has provided a solid foundation for the
catheter market to thrive. The region is home to some of the world’s leading
medical device manufacturers, such as Boston Scientific, Medtronic, Abbott
Laboratories, and Becton, Dickinson & Company (BD), which are at the
forefront of catheter innovations and production. Additionally, favourable
reimbursement policies and increased healthcare spending in the United States
and Canada have made advanced catheter-based treatments more accessible to
patients. The presence of regulatory agencies such as the U.S. Food and Drug
Administration (FDA) ensures strict quality control, fostering confidence in
catheter-based therapies. Regulatory approvals for novel catheters, including
biodegradable and antimicrobial-coated variants, have further strengthened the
region's leadership in the global market.
Recent Development
- In January 2025, B. Braun
Medical Inc. introduced the Clik-FIX Epidural/Peripheral Nerve Block (PNB)
Catheter Securement Device, expanding its Clik-FIX product line. Engineered for
a soft, low-profile, and secure fit, the device is designed to minimize
catheter displacement and dislodgement during regional anesthesia procedures.
Its user-friendly application and reliable securement address key challenges
faced by both patients and healthcare providers.
- In January 2025, Radical
Catheter Technologies announced that its 8F Neurovascular Catheter received
510(k) clearance from the U.S. Food and Drug Administration (FDA). Built on the
company’s proprietary ribbon technology platform, the 8F catheter features an
enlarged inner diameter, enhancing therapeutic options for neurovascular
interventions. The catheter’s advanced design offers flexibility, stability,
and durability, potentially improving procedural efficiency while reducing
risks and overall costs.
- In January 2025, Dr. Bruce
Gardner, a radiologist at Sanford Health, received FDA approval for his
innovative catheter design aimed at preventing accidental dislodgement
injuries. The catheter incorporates a unique mechanism that enables rapid
deflation of the retention balloon when excessive tension is applied,
mitigating patient risk and enhancing safety.
- In December 2024, Terumo
Interventional Systems (TIS), a division of Terumo Corporation, announced the
U.S. launch of the R2P NaviCross Peripheral Support Catheter, further
strengthening its radial-to-peripheral (R2P) portfolio. Featuring a 200 cm
length and a double-braided stainless-steel construction, the catheter is
designed for superior trackability and torque control, optimizing lesion
crossing in complex vascular procedures.
Key Market Players
- Hollister
Incorporated
- Medtronic
PLC
- Boston Scientific
Corporation
- Edward
Lifesciences
- Smith
Medical Inc.
- Teleflex
Incorporated
- ConvaTec
Group Plc
- Cure
Medical LLC
- Terumo
Corporation
- Cook
Medical Inc.
|
By Product Type
|
By End-use
|
By Region
|
- Cardiovascular Catheters
- Urology Catheters
- Intravenous Catheters
- Neurovascular Catheters
- Specialty Catheters
|
- Hospital Stores
- Retail Stores
- Others
-
|
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
|
Report Scope
In this report, the Global Catheter Market has been
segmented into the following categories, in addition to the industry trends
which have also been detailed below:
- Catheter Market, By Product Type:
o Cardiovascular Catheters
o Urology Catheters
o Intravenous Catheters
o Neurovascular Catheters
o Specialty Catheters
- Catheter Market, By End-use:
o Hospital Stores
o Retail Stores
o Others
- Catheter Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies
present in the Global Catheter Market.
Available Customizations:
Global Catheter Market report with the given market
data, TechSci Research offers customizations according to a company's specific
needs. The following customization options are available for the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
Global Catheter Market is an upcoming report to be
released soon. If you wish an early delivery of this report or want to confirm
the date of release, please contact us at sales@techsciresearch.com